Eiko LifeSciences Ltd (ELL) has entered an MoU with Vivacious Pharmatex. 

The salient features of the MoU are:

ELL to make a strategic investment in VPPL by way of acquiring a 5 per cent equity stake in VPPL.

Besides the amount of Strategic investment the expected additional outlay on account of Capital Expenditure, research and development will be approximately Rs 3 Crore (Rupees Three Crores Only)

ELL to assist VPPL in identifying, developing, and promoting new products and marketing thereof in the interest of both companies.

Both VPPL and ELL will use their manufacturing facilities/ expanded capacities to manufacture the products identified and developed by ELL.

ELL to be the preferred source of supply for some of the key Raw Materials to VPPL at "Arm's Length" transaction.

ELL to transfer technologies for Newly developed products (Cosmetic Emollients) to VPPL. As a result, VPPL to do manufacturing for and on behalf of the ELL.

All the products developed / co-developed and manufactured would be marketed by ELL

Laxmikant Kabra, Chairman and Director, Eiko LifeSciences said, "This is just the beginning of our fruitful relationship, and this association would help our business run smoothly. We shall continue to remain committed to the growth of our company and look forward to many more years of mutually beneficial association."